Meloxicam

Anjeso, Mobic, Qmiiz Odt, Vivlodex, Zynrelef (meloxicam) is a small molecule pharmaceutical. Meloxicam was first approved as Anjeso on 2000-04-13. It is used to treat osteoarthritis and rheumatoid arthritis in the USA. It has been approved in Europe to treat postoperative pain. The pharmaceutical is active against prostaglandin G/H synthase 2. In addition, it is known to target prostaglandin G/H synthase 1. Mobic's patents are valid until 2039-03-08 (FDA).